BlackRock Inc. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$1,701,000
+2.5%
1,710,0000.0%0.00%
Q3 2020$1,660,000
+0.2%
1,710,0000.0%0.00%
Q2 2020$1,656,000
+11.1%
1,710,000
+6.2%
0.00%
Q1 2020$1,490,000
+2.4%
1,610,000
+4.9%
0.00%
Q4 2019$1,455,000
-7.4%
1,535,000
-11.5%
0.00%
Q3 2019$1,571,000
+34.7%
1,735,000
+36.1%
0.00%
Q2 2019$1,166,000
-0.8%
1,275,0000.0%0.00%
Q1 2019$1,175,000
+15.8%
1,275,000
+13.3%
0.00%
Q4 2018$1,015,000
+17.3%
1,125,000
+21.6%
0.00%
Q3 2018$865,000
+28.7%
925,000
+27.6%
0.00%
Q2 2018$672,000
-21.4%
725,000
-25.6%
0.00%
Q1 2018$855,000
-39.4%
975,000
-39.4%
0.00%
Q4 2017$1,411,000
-2.6%
1,608,0000.0%0.00%
Q3 2017$1,449,000
+78.2%
1,608,000
+112.1%
0.00%
Q2 2017$813,000
+26.2%
758,000
+26.3%
0.00%
Q1 2017$644,000600,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders